Pharma Medica Research Inc. is a full service contract research organization headquartered in Toronto, Canada and recently expanded our operations into the USA through an acquisition of a clinical site in St. Louis, Missouri, making us one of the largest early phase CRO’s in the world! Our expansion to the USA has expanded our service offering & expertise, increased our capacity and allows for more flexible clinic scheduling.
We focus primarily on early phase clinical trials in healthy volunteers, special and patient populations. By remaining specialized in this area, we have developed true expertise in the field. Our track record speaks for itself – we helped bring over 300 drugs to markets around the world. Through an uncompromising commitment to quality and service, a reputation for on-time performance, innovation at all levels, and delivery of services at reasonable costs, we have become trusted partners of many of the world’s leading pharmaceutical companies.
We are a true customer focused organization and have consistently upheld our commitment to building long term relationships. This is not simply a buzz word used by our project management team, but is at the heart of the systems and decisions implemented throughout the entire company. By listening to our clients we have developed an organization that is efficient, effective, and responsive to evolving industry needs. We view ourselves as a true partner. Rather than ask clients to accommodate our processes, PMRI strives to better understand your needs and develop processes to accommodate them.
We recognize that as a drug developer you need a partner that offers flexible clinic scheduling, is responsive to change, is committed to quality and values scientific expertise. When faced with a last minute study request, a modification in study design, or a request to accelerate a final report, our processes and extensive resources allows us to accommodate your needs.
Our Head Office/Bioanlaytical laboratory currently operates in a 65,000 square foot, state-of-the-art facility. This allowed us to bring on board a greater number of industry leading scientists, and acquire more instruments to better service your needs.
Our Canadian clinical unit operates in a custom designed & built 115,000 square foot facility with 360 bed capacity. Designed to maximize operational efficiency and quality – the clinic operates 6 completely self-contained units.
In early 2014, we expanded our operation into the USA in St. Louis (St. Charles), Missouri. This 105,000 square foot clinical facility offers 520 bed capacity within 10 self-contained units. We have succeeded to implement uniform proven procedures and quality systems as our Canadian operation. This has allowed us to establish a truly seamless organization making it easy to work with us regardless of which clinical site conducts the study.
For more information contact: